Test Price
2,800 AED✅ Home Collection Available
TRIP11 Gene Achondrogenesis Type 1A Genetic Test (NGS) in UAE | 2,800 AED | DHA Licensed
Executive Summary & Core Metrics
Core Metrics
Test Overview & Methodology
This next-generation sequencing test comprehensively analyses the TRIP11 gene for pathogenic variants causing Achondrogenesis Type 1A – a severe, autosomal recessive skeletal dysplasia often fatal in the perinatal period. The assay provides full gene coverage, detecting single nucleotide variants, small insertions/deletions, and copy number variants with over 99.9% analytical sensitivity.
| Parameter | Our Test (TRIP11 NGS) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Diagnostic Precision | Full gene coverage, detection of SNVs, indels, CNVs | Targeted exon‑by‑exon; may miss deep intronic or copy‑number variants |
| Methodology | Next Generation Sequencing (Illumina® platform) | Sanger sequencing |
| Turnaround Time | 3‑4 Weeks | 4‑8 Weeks (limited throughput) |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
“Achondrogenesis Type 1A is a severe skeletal dysplasia that requires precise molecular confirmation. A positive TRIP11 result must be interpreted alongside detailed prenatal ultrasound and comprehensive genetic counselling. This test provides diagnostic clarity, but compassionate clinical follow-up and psychological support for families remain paramount.”
Advisory Notice
Do not discontinue any prescribed medication, especially prenatal vitamins or maternal medications, without consulting your treating physician. This test does not assess drug‑gene interactions and should not be used as a sole basis for treatment changes.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Patient is unwilling or unable to provide informed consent; sample collected from a minor without legal guardian presence; active systemic infection affecting DNA quality; sample type not matching pre‑approved kits.
- Emergency Red Flags: If the test reveals an unexpected pathogenic variant and you experience acute anxiety, suicidal ideation, or severe emotional distress, immediately contact your crisis support service or proceed to the nearest Emergency Department.
Patient FAQ & Clinical Guidance
1. Why is this TRIP11 NGS test recommended instead of a standard skeletal dysplasia panel?
This test delivers ultra‑high depth sequencing focused solely on the TRIP11 gene, achieving over 99.9% analytical sensitivity for the precise pathogenic variants that cause Achondrogenesis Type 1A. It is the most definitive molecular method for confirmation when clinical suspicion is high.
2. Can the sample be collected at home and how is it kept stable during transport?
Yes, our certified phlebotomists perform home collection using validated temperature‑controlled cold‑chain packaging that maintains specimen integrity from your doorstep to our ISO‑certified laboratory. The service is available daily from 8 AM to 11 PM.
3. How will I receive the results and what support is available afterwards?
You will receive a secure, interpreted PDF report within 3‑4 weeks. Following delivery, a dedicated specialist will conduct a telephonic counselling session to explain the clinical implications and guide next steps.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance
This diagnostic service operates in full compliance with UAE Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is processed under strict confidentiality and security protocols. Clinical testing safety and patient consent adhere to Federal Decree‑Law No. 4 of 2016 on Medical Liability. The laboratory holds ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | TRIP11 Gene Achondrogenesis Type 1A Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral whole blood, extracted DNA, or FTA card blood spot |
| Methodology Used | Next Generation Sequencing (NGS) on Illumina platform |
| ICD-10-CM Code | Q77.1 (Achondrogenesis) |
| LOINC Code | 51966-0 |
| DHA Facility License & Laboratory Address | DHA Facility License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians